SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiotechnology
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (12)7/3/2000 4:42:30 AM
From: Mike McFarland  Read Replies (1) of 16
 
HYPNOTICS, SEDATIVES AND ANXIOLYTICS
mssm.edu

I thought I posted this once before, but I don't see it,
memory impariment I suppose.

Although the benzodiazepines are regarded as much less potent respiratory depressants than the barbiturates, they are not entirely safe in this regard (for example, when given to patients with compromised bronchopulmonary function, or in patients with obstructive sleep apnea where hypnotic doses can exaggerate apneic episodes). However, when benzodiazepines have been taken alone in overdose – without any other drugs or alcohol – the outcome usually has been benign, even when the dose has been rather large.

Ambien <ZOLPIDEM TARTRATE>
Zolpidem is a non-benzodiazepine that exhibits selectivity among GABAA receptors of varying subunit composition.
Although respiratory depression appears minimal, zolpidem does exacerbate obstructive sleep apnea syndrome

even better source of info on Ambien:
searlehealthnet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News